Sotac Pharmaceuticals (NSE:SOTAC) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SOTAC Sotac Pharmaceuticals Ltd NSE:SOTAC
58 GF Score
Price ₹95.10
GF Value ₹140.93
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Sotac Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

NSE:SOTAC
58GF Score
Sotac Pharmaceuticals Ltd NSE:SOTAC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sotac Pharmaceuticals (NSE:SOTAC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotac Pharmaceuticals stock appears to be undervalued. The current stock price of ₹95.10 is trading 32.5% below its estimated GF Value™ of ₹140.93. GuruFocus considers Sotac Pharmaceuticals to be Significantly Undervalued.

Key valuation signals for NSE:SOTAC:

  • FFO:
  • GF Value™: ₹140.93 vs. price of ₹95.10 (32.5% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the NSE:SOTAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sotac Pharmaceuticals Business Description

Address Plot No. PF-21 & PF-22/A, Charal Industrial Estate, Sanand GIDC-II, Sanand, Ahmedabad, GJ, IND, 382110
Sotac Pharmaceuticals Ltd operates chiefly in pharmaceutical manufacturing, serving a broad range of therapeutic segments including anti-diabetic, anti-psychotic, vitamins and minerals, anti-cold, anti-allergic, derma products, antacids, anti-ulcerants, cardiac, analgesic, anti-bacterial, anti-fungal, and more. The company manufactures tablets, capsules, syrups, and external preparations under contract manufacturing and loan licensing agreements, for domestic and international markets. Its clients include notable pharmaceutical marketers such as Cadila Pharma and Viatris. Revenue is distributed between domestic pharmaceutical product sales and international exports, supporting scalable growth across geographies.
58GF Score

Get the complete analysis for NSE:SOTAC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹95.10
Price
₹140.93
GF Value